ALPHA TEKNOVA, INC. Operating Lease Cost
ALPHA TEKNOVA, INC. (TKNO) reported Operating Lease Cost of $669.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-06
- ALPHA TEKNOVA, INC. operating lease, cost for the quarter ending 2026-06-30 was $669.00K, a 2.19% decline year-over-year.
- ALPHA TEKNOVA, INC. operating lease, cost for the quarter ending 2026-03-31 was $669.00K, a 2.19% decline year-over-year.
- ALPHA TEKNOVA, INC. operating lease, cost for the quarter ending 2025-12-31 was $682.00K, a 8.46% decline year-over-year.
- ALPHA TEKNOVA, INC. operating lease, cost for the quarter ending 2025-09-30 was $685.00K, a 8.05% decline year-over-year.
- ALPHA TEKNOVA, INC. operating lease, cost for fiscal 2025 was $2.73M, a 8.25% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. operating lease, cost for fiscal 2024 was $2.98M, a 11.31% increase from fiscal 2023.
- ALPHA TEKNOVA, INC. operating lease, cost for fiscal 2023 was $2.68M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $669.00K 10-Q · filed 2026-08-06 | $1.34M 10-Q · filed 2026-08-06 | $2.02M derived: sum of 3 quarters · filed 2026-08-06 | $2.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $669.00K 10-Q · filed 2026-05-07 | $1.35M derived: sum of 2 quarters · filed 2026-05-07 | $2.04M derived: sum of 3 quarters · filed 2026-05-07 | $2.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $682.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.37M derived: sum of 2 quarters · filed 2026-03-02 | $2.05M derived: sum of 3 quarters · filed 2026-08-06 | $2.73M 10-K · filed 2026-03-02 |
| 2025-09-30 | $685.00K 10-Q · filed 2025-11-07 | $1.37M derived: sum of 2 quarters · filed 2026-08-06 | $2.05M 10-Q · filed 2025-11-07 | $2.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $684.00K 10-Q · filed 2026-08-06 | $1.37M 10-Q · filed 2026-08-06 | $2.11M derived: sum of 3 quarters · filed 2026-08-06 | $2.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $684.00K 10-Q · filed 2026-05-07 | $1.43M derived: sum of 2 quarters · filed 2026-05-07 | $2.17M derived: sum of 3 quarters · filed 2026-05-07 | $2.92M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $745.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.49M derived: sum of 2 quarters · filed 2026-03-02 | $2.23M derived: sum of 3 quarters · filed 2026-03-02 | $2.98M 10-K · filed 2026-03-02 |
| 2024-09-30 | $745.00K 10-Q · filed 2025-11-07 | $1.49M derived: sum of 2 quarters · filed 2025-11-07 | $2.24M 10-Q · filed 2025-11-07 | $2.87M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $745.00K 10-Q · filed 2025-08-08 | $1.49M 10-Q · filed 2025-08-08 | $2.13M derived: sum of 3 quarters · filed 2025-08-08 | $2.77M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $745.00K 10-Q · filed 2025-05-09 | $1.38M derived: sum of 2 quarters · filed 2025-05-09 | $2.02M derived: sum of 3 quarters · filed 2025-05-09 | $2.66M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.28M derived: sum of 2 quarters · filed 2025-03-07 | $1.92M derived: sum of 3 quarters · filed 2025-03-07 | $2.68M 10-K · filed 2025-03-07 |
| 2023-09-30 | $640.00K 10-Q · filed 2024-11-08 | $1.28M derived: sum of 2 quarters · filed 2024-11-08 | $2.04M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $641.00K 10-Q · filed 2024-08-13 | $1.40M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $761.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |